已收盘 08-01 16:00:00 美东时间
-0.300
-0.98%
New Amsterdam Pharma will host a conference call and webcast on July 30, 2025, at 10:00 a.m. ET to discuss Alzheimer's Disease biomarker data from the BROADWAY clinical trial. Featured speakers include Philip Scheltens, M.D., Ph.D., Kellyann Niotis, M.D., and Nathaniel Chin, M.D.
07-22 12:00
Mizuho analyst Peter Costa initiates coverage on NAPCO Security Techs (NASDAQ:NSSC) with a Outperform rating and announces Price Target of $39.
07-10 21:09
潜在涨幅312.09%!HC Wainwright & Co.上调内克塔治疗目标价至120美元,维持"买入"评级;联邦快递遭多家机构下调目标价>>
06-26 08:38
DA Davidson analyst Matt Summerville maintains NAPCO Security Techs (NASDAQ:NSSC) with a Buy and raises the price target from $30 to $33.
06-25 22:52
Nature's Sunshine Products announced an underwritten secondary public offering of up to 2,854,607 shares of common stock by Fosun Pharma USA, Inc. The company does not sell any shares and will not receive proceeds. Fosun Pharma covers underwriting costs and related expenses, while Nature's Sunshine bears registration costs. The company may repurchase up to $15 million of shares under its share repurchase program, funded by cash and credit facilit...
06-25 20:01
Aclass actionlawsuit was filed againstNapco Security Technolo...
05-29 19:47
NewAmsterdam Pharma announced it will participate in three upcoming investor conferences in June 2025: the William Blair 45th Annual Growth Stock Conference in Chicago with CEO Michael Davidson presenting on June 3, the Jefferies Global Healthcare Conference in New York with CFO Ian Somaiya in a fireside chat on June 4, and the Goldman Sachs 46th Annual Healthcare Conference in Miami with CEO Michael Davidson and Executive Vice President Matthew ...
05-27 12:00
Napco Security (($NSSC)) has held its Q3 earnings call. Read on for the main hi...
05-07 08:55
The latest announcement is out from Napco Security Technologies ( ($NSSC) ). On...
05-06 01:47
Companies Reporting Before The Bell • Recursion Pharmaceuticals (NASDAQ:RXRX) i...
05-05 16:32